Company: ARMP
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001104659-25-040273
Chunk: 52

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 52
---
045 | ​ | ​ |
| 2022    | ​ | ​ | ​                                                                          | ​ | 1,639,908 | ​ | ​ | ​ | ​                                       | ​ |  -347,905 | ​ | ​ | ​ | ​                                             | ​ |       — | ​ | ​ | ​ | ​                                       | ​ |       — | ​ | ​ | ​ | ​                                                                                    | ​ | 586,033 | ​ | ​ | ​ | ​                                                    | ​ | 278,524 | ​ | ​ | ​ | ​                                                                              | ​ | 22 | ​ | ​ | ​ | ​                           | ​ | -36,917 | ​ | ​ |

(1) We are a smaller reporting company pursuant to Rule 405 of the Securities Act of 1933, and as such, we are only required to include information for the past three fiscal years in this table. (2) The dollar amounts reported in column (b) for the fiscal year 2024 is the amount of total compensation reported for Dr. Birx(“PEO 1”). The dollar amounts reported in columns (b) and (d) for the fiscal year 2023 is the amounts of total compensation reported for Dr. Birx (our Chief Executive Officer since July 10, 2023) (“PEO 1”) and Dr. Varnum (our Chief Executive Officer until July 10, 2023) (“PEO 2”), respectively. The dollar amounts reported in columns (b) and (d) for the fiscal year 2022 are the amount of total compensation reported for Dr. Varnum (our Chief Executive Officer until July 10, 2023) (“PEO 1”). Refer to “Executive Compensation - Summary Compensation Table” above. (3) The dollar amounts reported in columns (c) and (e) represent the amount of “compensation actually paid” to Dr. Birx and Dr. Varnum, respectively, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid to Dr. Birx and Dr. Varnum during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the adjustments made to Dr. Birx’s and Dr. Varnum’s total compensation for each year to determine the compensation actually paid are shown in the “Adjustments to Compensation Actually Paid” table below. (4